Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
electroCore is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $3.5M | $5.5M | $8.6M | $16.0M | $25.2M | $32.0M |
| Gross profit | $1.8M | $4.1M | $7.0M | $13.2M | $21.4M | $27.8M |
| Operating income | -$24.7M | -$20.0M | -$22.9M | -$19.3M | -$12.2M | -$13.2M |
| Net income | -$23.5M | -$17.2M | -$22.2M | -$18.8M | -$11.9M | -$14.0M |
| Diluted EPS | — | -$4.36 | -$4.69 | -$3.42 | -$1.59 | -$1.65 |
| Operating cash flow | -$20.1M | -$13.6M | -$16.6M | -$14.7M | -$6.9M | -$8.2M |
| Free cash flow | — | — | — | -$14.9M | — | -$8.3M |
| Gross margin | 50.3% | 74.6% | 81.2% | 82.5% | 85.0% | 86.8% |
| Operating margin | -707.9% | -367.7% | -266.2% | -120.2% | -48.3% | -41.1% |
| Net margin | -672.5% | -315.9% | -257.9% | -117.5% | -47.2% | -43.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.1M | $6.6M | $7.0M | $6.7M | $7.4M | $8.7M | $9.2M | $9.6M |
| Gross profit | $5.3M | $5.5M | $6.1M | $5.7M | $6.4M | $7.5M | $8.2M | $8.4M |
| Operating income | -$2.6M | -$2.7M | -$3.1M | -$3.8M | -$3.5M | -$2.9M | -$2.9M | -$5.3M |
| Net income | -$2.7M | -$2.5M | -$3.2M | -$3.9M | -$3.7M | -$3.4M | -$3.0M | -$5.3M |
| Diluted EPS | -$0.38 | -$0.31 | -$0.37 | -$0.47 | -$0.44 | -$0.40 | -$0.34 | -$0.59 |
| Operating cash flow | -$1.8M | -$1.4M | -$1.3M | -$4.4M | -$623,000.00 | -$1.7M | -$1.5M | -$3.0M |
| Free cash flow | — | — | — | -$4.4M | -$648,000.00 | -$1.7M | -$1.5M | -$3.0M |
| Gross margin | 86.3% | 83.8% | 85.9% | 84.9% | 87.3% | 86.0% | 88.4% | 87.3% |
| Operating margin | -42.2% | -40.4% | -43.6% | -56.9% | -47.5% | -33.2% | -31.8% | -55.5% |
| Net margin | -43.2% | -38.1% | -45.8% | -57.4% | -49.7% | -39.2% | -32.8% | -55.0% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-28 | Lev Joshua S.· CFO and Interim President | Sale | 6,667 | $9.00 | $60,003.00 | filing |
| 2026-05-22 | Lev Joshua S.· CFO and Interim President | Sale | 3,000 | $6.50 | $19,500.00 | filing |
| 2026-05-21 | Errico Thomas J. | Buy | 9,992 | $5.99 | $59,852.08 | filing |
| 2026-05-20 | Errico Thomas J. | L | 8 | $5.98 | $47.84 | filing |
| 2026-04-23 | Goldberger Daniel S | Sale | 80,000 | $6.80 | $544,000.00 | filing |
| 2026-04-13 | Fox Michael· Chief Operating Officer | Award | 70,000 | $0.00 | $0.00 | filing |
| 2026-04-10 | Goldberger Daniel S | Sale | 16,072 | $6.02 | $96,753.44 | filing |
| 2026-04-01 | Lev Joshua S.· CFO and Interim President | Award | 45,000 | $0.00 | $0.00 | filing |
| 2026-03-19 | Errico Thomas J. | X | 19,252 | $6.43 | $123,790.36 | filing |
| 2026-03-19 | Errico Thomas J. | X | 22,803 | $4.35 | $99,193.05 | filing |
| 2026-01-26 | Goldberger Daniel S· Chief Executive Officer | Award | 20,375 | $7.47 | $152,201.25 | filing |
| 2026-01-26 | Goldberger Daniel S· Chief Executive Officer | Award | 26,000 | $0.00 | $0.00 | filing |
| 2026-01-26 | Lev Joshua S.· Chief Financial Officer | Award | 2,889 | $0.00 | $0.00 | filing |
| 2026-01-26 | Lev Joshua S.· Chief Financial Officer | Award | 25,000 | $0.00 | $0.00 | filing |
| 2025-12-04 | Lev Joshua S.· Chief Financial Officer | Sale | 2,500 | $5.05 | $12,625.00 | filing |
| 2025-12-02 | Goldberger Daniel S· Chief Executive Officer | Buy | 1,000 | $4.84 | $4,840.00 | filing |
| 2025-11-12 | Lev Joshua S.· Chief Financial Officer | Sale | 2,166 | $6.18 | $13,385.88 | filing |
| 2025-09-10 | Bonfiglioli Elena | Award | 30,549 | $0.00 | $0.00 | filing |
| 2025-09-02 | Wilber Patricia | Award | 19,011 | $0.00 | $0.00 | filing |
| 2025-09-02 | Goldstein Julie Ann | Award | 19,011 | $0.00 | $0.00 | filing |
| 2025-09-02 | Errico Thomas J. | Award | 26,615 | $0.00 | $0.00 | filing |
| 2025-09-02 | GANDOLFO JOHN P | Award | 19,011 | $0.00 | $0.00 | filing |
| 2025-09-02 | PATTON THOMAS M | Award | 19,011 | $0.00 | $0.00 | filing |
| 2025-08-11 | Errico Thomas J. | Buy | 15,000 | $4.47 | $67,050.00 | filing |
| 2025-08-11 | Goldberger Daniel S· Chief Executive Officer | Buy | 1,000 | $4.23 | $4,230.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.